142
Views
63
CrossRef citations to date
0
Altmetric
Review

Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients

, &
Pages 675-687 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Gerardo Botti, Margherita Cerrone, Giosuè Scognamiglio, Annamaria Anniciello, Paolo Antonio Ascierto & Monica Cantile. (2013) Microenvironment and tumor progression of melanoma: New therapeutic prospectives. Journal of Immunotoxicology 10:3, pages 235-252.
Read now
Wenfang Shi, Cunye Qu & Qijun Qian. (2007) Trends in therapeutic monoclonal antibodies of cancer. Expert Opinion on Therapeutic Patents 17:9, pages 1047-1059.
Read now

Articles from other publishers (60)

Fengqing Fu, Meng Zheng, Shandong Zhao, Yan Wang, Minzhou Huang, Hanqing Chen, Ziyi Huang, Kaijie Zhang, Liyan Miao & Xueguang Zhang. (2023) Therapeutic Characterization of 131I-Labeled Humanized Anti-B7-H3 Antibodies for Radioimmunotherapy for Glioblastoma. Engineering.
Crossref
Xin Huang, Shuyou Shi, Hongrui Wang, Tiesuo Zhao, Yibo Wang, Sihua Huang, Yingying Su, Chunyan Zhao & Ming Yang. (2023) Advances in antibody-based drugs and their delivery through the blood-brain barrier for targeted therapy and immunotherapy of gliomas. International Immunopharmacology 117, pages 109990.
Crossref
Zaixiang Fu, Ganggui Zhu, Chao Luo, Zihang Chen, Zhangqi Dou, Yike Chen, Chen Zhong, Sheng Su & Fuyi Liu. (2022) Matricellular protein tenascin C: Implications in glioma progression, gliomagenesis, and treatment. Frontiers in Oncology 12.
Crossref
Julie Rousseau, Joseph Lau & François Bénard. 2022. Nuclear Medicine and Immunology. Nuclear Medicine and Immunology 297 345 .
Sayda Dhaouadi, Rahma Ben Abderrazek, Thomas Loustau, Chérine Abou-Faycal, Ayoub Ksouri, William Erne, Devadarssen Murdamoothoo, Matthias Mörgelin, Andreas Kungl, Alain Jung, Sonia Ledrappier, Zakaria Benlasfar, Sandrine Bichet, Ruth Chiquet-Ehrismann, Ismaïl Hendaoui, Gertraud Orend & Balkiss Bouhaouala-Zahar. (2021) Novel Human Tenascin-C Function-Blocking Camel Single Domain Nanobodies. Frontiers in Immunology 12.
Crossref
Barbara Carreira, Rita C. Acúrcio, Ana I. Matos, Carina Peres, Sabina Pozzi, Daniella Vaskovich‐Koubi, Ron Kleiner, Mariana Bento, Ronit Satchi‐Fainaro & Helena F. Florindo. (2020) Nanomedicines as Multifunctional Modulators of Melanoma Immune Microenvironment. Advanced Therapeutics 4:1, pages 2000147.
Crossref
Christopher Farrell, Wenyin Shi, Alexa Bodman & Jeffrey J. Olson. (2020) Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma. Journal of Neuro-Oncology 150:2, pages 269-359.
Crossref
Sayda Dhaouadi, Devadarssen Murdamoothoo, Asma Tounsi, William Erne, Rahma Benabderrazek, Zakaria Benlasfar, Lotfi Hendaoui, Ruth Chiquet-Ehrismann, Samir Boubaker, Gertraud Orend, Ismaïl Hendaoui & Balkiss Bouhaouala-Zahar. (2020) Generation and characterization of dromedary Tenascin-C and Tenascin-W specific antibodies. Biochemical and Biophysical Research Communications 530:2, pages 471-478.
Crossref
Karin Huizer, Changbin Zhu, Ihsan Chirifi, Bart Krist, Denise Zorgman, Marcel van der Weiden, Thierry P P van den Bosch, Jasper Dumas, Caroline Cheng, Johan M Kros & Dana A Mustafa. (2020) Periostin Is Expressed by Pericytes and Is Crucial for Angiogenesis in Glioma. Journal of Neuropathology & Experimental Neurology 79:8, pages 863-872.
Crossref
Fatih Yalcin, Omar Dzaye & Shuli Xia. 2020. Tumor Microenvironment. Tumor Microenvironment 149 172 .
Ali Gholamrezanezhad, Hossein Shooli, Narges Jokar, Reza Nemati & Majid Assadi. (2019) Radioimmunotherapy (RIT) in Brain Tumors. Nuclear Medicine and Molecular Imaging 53:6, pages 374-381.
Crossref
Joshua Loya, Charlie Zhang, Emily Cox, Achal S Achrol & Santosh Kesari. (2019) Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy. CNS Oncology 8:3, pages CNS40.
Crossref
Maryline G. Ferrier, Valery Radchenko & D. Scott Wilbur. (2019) Radiochemical aspects of alpha emitting radionuclides for medical application. Radiochimica Acta 107:9-11, pages 1065-1085.
Crossref
Hans-Jürgen Reulen, Eric Suero Molina, Reinhard Zeidler, Franz Josef Gildehaus, Guido Böning, Astrid Gosewisch & Walter Stummer. (2019) Intracavitary radioimmunotherapy of high-grade gliomas: present status and future developments. Acta Neurochirurgica 161:6, pages 1109-1124.
Crossref
Giulia Mazzoccanti, Giuseppe Pierri, Alessia Ciogli, Omar H. Ismail, Fabrizio Giorgi, Rita De Santis, Claudio Villani & Francesco Gasparrini. (2018) Stepwise “bridge‐to‐bridge” reduction of monoclonal antibodies and light chain detection: Case studies of tenatumomab and trastuzumab. SEPARATION SCIENCE PLUS 1:4, pages 261-269.
Crossref
Mohan S. Nandhu, Prajna Behera, Vivek Bhaskaran, Sharon L. Longo, Lina M. Barrera-Arenas, Sadhak Sengupta, Diego J. Rodriguez-Gil, E. Antonio Chiocca & Mariano S. Viapiano. (2018) Development of a Function-Blocking Antibody Against Fibulin-3 as a Targeted Reagent for Glioblastoma. Clinical Cancer Research 24:4, pages 821-833.
Crossref
STEVEN DE VLEESCHOUWER & GABRIELE BERGERS. 2017. Glioblastoma. Glioblastoma 315 340 .
Raghu Raghavan, Roger W Howell & Michael R Zalutsky. (2017) A model for optimizing delivery of targeted radionuclide therapies into resection cavity margins for the treatment of primary brain cancers. Biomedical Physics & Engineering Express 3:3, pages 035005.
Crossref
Satoshi Okawa, Sladjana Gagrica, Carla Blin, Christine Ender, Steven M. Pollard & Jeroen Krijgsveld. (2017) Proteome and Secretome Characterization of Glioblastoma-Derived Neural Stem Cells. Stem Cells 35:4, pages 967-980.
Crossref
Robert C. BastJr.Jr., Michael R. Zalutsky & Arthur E. Frankel. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine 1 23 .
Dewen Yang. (2016) Standardized MRI assessment of high-grade glioma response: a review of the essential elements and pitfalls of the RANO criteria. Neuro-Oncology Practice 3:1, pages 59-67.
Crossref
Andrew J. Sawyer & Themis R. Kyriakides. (2016) Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization. Advanced Drug Delivery Reviews 97, pages 56-68.
Crossref
Hans-Juergen ReulenGabriele PoepperlClaudia GoetzFranz Joseph GildehausMichael Schmidt, Klaus TatschTorsten Pietsch, Theo Kraus & Walter Rachinger. (2015) Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy. Journal of Neurosurgery 123:3, pages 760-770.
Crossref
François Autelitano, Denis Loyaux, Sébastien Roudières, Catherine Déon, Frédérique Guette, Philippe Fabre, Qinggong Ping, Su Wang, Romane Auvergne, Vasudeo Badarinarayana, Michael Smith, Jean-Claude Guillemot, Steven A. Goldman, Sridaran Natesan, Pascual Ferrara & Paul August. (2014) Identification of Novel Tumor-Associated Cell Surface Sialoglycoproteins in Human Glioblastoma Tumors Using Quantitative Proteomics. PLoS ONE 9:10, pages e110316.
Crossref
Thaddeus J. WadasDarpan N. PandyaKiran Kumar Solingapuram SaiAkiva Mintz. (2014) Molecular Targeted α-Particle Therapy for Oncologic Applications. American Journal of Roentgenology 203:2, pages 253-260.
Crossref
Jia Lin, Sarah Shigdar, Ding Zhi Fang, Dognxi Xiang, Ming Q. Wei, Andrew Danks, Lingxue Kong, Lianghong Li, Liang Qiao & Wei Duan. (2014) Improved Efficacy and Reduced Toxicity of Doxorubicin Encapsulated in Sulfatide-Containing Nanoliposome in a Glioma Model. PLoS ONE 9:7, pages e103736.
Crossref
Congzhou Wang & Vamsi K. Yadavalli. (2014) Investigating biomolecular recognition at the cell surface using atomic force microscopy. Micron 60, pages 5-17.
Crossref
Pasquale De BonisGiorgio Lofrese, Carmelo Anile, Angelo Pompucci, Vera Vigo & Annunziato Mangiola. (2013) Radioimmunotherapy for high-grade glioma. Immunotherapy 5:6, pages 647-659.
Crossref
Yongjun Li, Haiyan Qiao, Wei Yan, Jing Zhang, Chunyan Xing, Hongda Wang, Bailin Zhang & Jilin Tang. (2013) Molecular recognition force spectroscopy study of the dynamic interaction between aptamer GBI-10 and extracellular matrix protein tenascin-C on human glioblastoma cell. Journal of Molecular Recognition 26:1, pages 46-50.
Crossref
Florence Brellier, Enrico Martina, Martin Degen, Nathalie Heuzé-Vourc’h, Agnès Petit, Thomas Kryza, Yves Courty, Luigi Terracciano, Christian Ruiz & Ruth Chiquet-Ehrismann. (2012) Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors. BMC Clinical Pathology 12:1.
Crossref
Van Nguyen, Jesse M. Conyers, Dongqin Zhu, Denise M. Gibo, Roy R. Hantgan, Steven M. Larson, Waldemar Debinski & Akiva Mintz. (2012) A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Rα2 tumor-restricted biomarker. Neuro-Oncology 14:10, pages 1239-1253.
Crossref
Alia Hdeib & Andrew Sloan. (2012) Targeted radioimmunotherapy: the role of 131 I-chTNT-1/B mAb (Cotara ® ) for treatment of high-grade gliomas . Future Oncology 8:6, pages 659-669.
Crossref
Alphonse E. Sirica. (2011) The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Nature Reviews Gastroenterology & Hepatology 9:1, pages 44-54.
Crossref
Griffith R. HarshIVIV. 2012. Schmidek and Sweet Operative Neurosurgical Techniques. Schmidek and Sweet Operative Neurosurgical Techniques 127 140 .
Deana Marshall, Duane A. Mitchell, Michael W. Graner & Darell D. Bigner. 2012. Neuro-Oncology. Vol 104 HCN Series. Neuro-Oncology. Vol 104 HCN Series 309 330 .
Lewis Hou & Griffith R. HarshIVIV. 2012. Brain Tumors. Brain Tumors 347 371 .
Masahiro Toda. 2012. Glioma. Glioma 77 84 .
Kevin S. Chen & Duane A. Mitchell. 2012. Glioma. Glioma 121 141 .
Gabriele Pöpperl. 2014. Therapeutic Nuclear Medicine. Therapeutic Nuclear Medicine 187 198 .
Thomas C. Kwee, Sandip Basu, Harshad R. Kulkarni, Richard P. Baum & Abass Alavi. 2014. Therapeutic Nuclear Medicine. Therapeutic Nuclear Medicine 917 929 .
David M. Goldenberg & Robert M. Sharkey. 2014. Therapeutic Nuclear Medicine. Therapeutic Nuclear Medicine 125 138 .
Yan Michael Li & Walter A Hall. (2011) Cell Surface Receptors in Malignant Glioma. Neurosurgery 69:4, pages 980-994.
Crossref
David M GoldenbergRobert M Sharkey. (2011) Recent progress in cancer therapy with radiolabeled monoclonal antibodies. Therapeutic Delivery 2:6, pages 675-679.
Crossref
Y.-M. Yu, M. Cristofanilli, A. Valiveti, L. Ma, M. Yoo, F. Morellini & M. Schachner. (2011) The extracellular matrix glycoprotein tenascin-C promotes locomotor recovery after spinal cord injury in adult zebrafish. Neuroscience 183, pages 238-250.
Crossref
Alphonse E Sirica, Deanna J Campbell & Catherine I Dumur. (2011) Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma. Current Opinion in Gastroenterology 27:3, pages 276-284.
Crossref
Marc Hens, Ganesan Vaidyanathan, Xiao-Guang Zhao, Darell D. Bigner & Michael R. Zalutsky. (2010) Anti-EGFRvIII monoclonal antibody armed with 177Lu: in vivo comparison of macrocyclic and acyclic ligands. Nuclear Medicine and Biology 37:7, pages 741-750.
Crossref
Tim Fugmann, Dario Neri & Christoph Roesli. (2010) DeepQuanTR: MALDI‐MS‐based label‐free quantification of proteins in complex biological samples. PROTEOMICS 10:14, pages 2631-2643.
Crossref
Alexander Sturzu, Hubert Kalbacher, Hartmut Echner, Uwe Klose, Alireza Gharabaghi & Stefan Heckl. (2009) Imaging of human glioma cells by means of a Syndecan-4 directed DOTA-conjugate. Amino Acids 38:5, pages 1415-1421.
Crossref
Enrico Martina, Martin Degen, Curzio Ruegg, Adrian Merlo, Maddalena M. Lino, Ruth Chiquet‐Ehrismann & Florence Brellier. (2009) Tenascin‐W is a specific marker of glioma‐associated blood vessels and stimulates angiogenesis in vitro . The FASEB Journal 24:3, pages 778-787.
Crossref
Stefanie Burghaus, Annett Hölsken, Michael Buchfelder, Rudolf Fahlbusch, Beat M. Riederer, Volkmar Hans, Ingmar Blümcke & Rolf Buslei. (2010) A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas. Virchows Archiv 456:3, pages 287-300.
Crossref
Siddhartha Mitra, Gordon Li & Griffith R. HarshIVIV. (2010) Passive Antibody-Mediated Immunotherapy for the Treatment of Malignant Gliomas. Neurosurgery Clinics of North America 21:1, pages 67-76.
Crossref
Michael W. Graner, Deborah A. Raynes, Darell D. Bigner & Vince Guerriero. (2009) Heat shock protein 70-binding protein 1 is highly expressed in high-grade gliomas, interacts with multiple heat shock protein 70 family members, and specifically binds brain tumor cell surfaces. Cancer Science 100:10, pages 1870-1879.
Crossref
Victoria L. Heath & Roy Bicknell. (2009) Anticancer strategies involving the vasculature. Nature Reviews Clinical Oncology 6:7, pages 395-404.
Crossref
Daniel J. Silver & Dennis A. Steindler. (2009) Common astrocytic programs during brain development, injury and cancer. Trends in Neurosciences 32:6, pages 303-311.
Crossref
Giuseppe Donato, Francesco Conforti, Valeria Zuccalà, Emilio Russo, Lorenza Maltese, Ida Perrotta & Andrea Amorosi. (2009) Expression of tenascin-c and CD44 receptors in cardiac myxomas. Cardiovascular Pathology 18:3, pages 173-177.
Crossref
Rachael A Hancox, Michael D Allen, Deborah L Holliday, Dylan R Edwards, Caroline J Pennington, David S Guttery, Jacqueline A Shaw, Rosemary A Walker, J Howard Pringle & J Louise Jones. (2009) Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms. Breast Cancer Research 11:2.
Crossref
Uta Behrends & Josef Mautner. 2009. Tumor‐Associated Antigens. Tumor‐Associated Antigens 113 141 .
Marc Hens, Ganesan Vaidyanathan, Phil Welsh & Michael R. Zalutsky. (2009) Labeling internalizing anti-epidermal growth factor receptor variant III monoclonal antibody with 177Lu: in vitro comparison of acyclic and macrocyclic ligands. Nuclear Medicine and Biology 36:2, pages 117-128.
Crossref
Robert M. Sharkey & David M. Goldenberg. (2008) Use of antibodies and immunoconjugates for the therapy of more accessible cancers. Advanced Drug Delivery Reviews 60:12, pages 1407-1420.
Crossref
Ruty Mehrian ShaiJuergen KV ReichardtThomas C Chen. (2008) Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas. Future Oncology 4:4, pages 525-534.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.